In liver disease, glucose metabolism shifts from the liver to muscle and adipose tissue, which stimulates mitochondrial oxidative stress and drives the production of proinflammatory adipokines, e.g., leptin, tumor necrosis factors-alpha and interleukin-6 [59]. Here, IL6 is linked to liver disorder.